Xolair auto-injectors exposed to temperatures outside labeled storage requirements
Xolair (omalizumab injection) 150 mg/mL auto-injectors are being recalled because of CGMP deviations: the product was exposed to temperatures outside its labeled storage requirements. 6 units affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall over a storage temperature excursion, with no confirmed potency or stability failure stated in the source.
Plain-English summary
Xolair (omalizumab injection), 150 mg/mL, 1 auto-injector, prescription only, from Genentech, Inc. of South San Francisco, California, NDC 50242-215-55, is being recalled. The action covers 6 units.
The stated reason is CGMP deviations: the product was exposed to temperatures outside the product's labeled storage requirements. The FDA classified the action as Class II. The source does not report any confirmed loss of potency or stability.
The affected lot is 3617756, expiring 12/31/2025. Distribution was nationwide within the US.
Patients and facilities holding the affected lot should follow the instructions issued by Genentech.
The recalled product
- Product
- XOLAIR (OMALIZUMAB)
- Brand
- XOLAIR
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Injectable biologic
- Affected units
- 6
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 3617756
- Expires: 12/31/2025.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · XOLAIR
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateGenentech Xolair Injection Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-07-14
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
- CriticalEye Drops Recalled for Non-Sterility Issues from Manufacturing Facility
FDA (Drugs) · 2023-11-29
- SevereEye drops recalled for non-sterility due to bacterial contamination
FDA (Drugs) · 2023-11-29
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- HighAbbott Diagnostics Architect Total T36X4ML Calibrator Cold Chain Excursion
FDA (Devices) · 2025-06-04